Tapering thrombopoietin receptor agonists in primary immune thrombocytopenia: Expert consensus based on the RAND/UCLA modified Delphi panel method

BACKGROUND: Thrombopoietin receptor agonists (TPO‐RAs) are used to treat primary immune thrombocytopenia (ITP). Some patients have discontinued treatment while maintaining a hemostatic platelet count. OBJECTIVES: To develop expert consensus on when it is appropriate to consider tapering TPO‐RAs in I...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuker, Adam, Despotovic, Jenny M., Grace, Rachael F., Kruse, Caroline, Lambert, Michele P., Liebman, Howard A., Lyons, Roger M., McCrae, Keith R., Pullarkat, Vinod, Wasser, Jeffrey S., Beenhouwer, David, Gibbs, Sarah N., Yermilov, Irina, Broder, Michael S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles ‐ Hemostasis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845076/
https://www.ncbi.nlm.nih.gov/pubmed/33537531
http://dx.doi.org/10.1002/rth2.12457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845076/
https://www.ncbi.nlm.nih.gov/pubmed/33537531
http://dx.doi.org/10.1002/rth2.12457

Ejemplares similares